Loss of abdominal fat may be key to reversing prediabetes

Prediabetes is a condition that precedes type 2 diabetes and increases the risk of heart attack, kidney and eye disease, and several types of cancer. Currently, there is no approved drug therapy for prediabetes available.

Wastewater clues could revolutionize Alzheimer’s detection

Review explores the potential of wastewater-based epidemiology (WBE) for diagnosing Alzheimer’s disease (AD) through biomarkers in biofluids, offering a non-invasive, cost-effective approach to early detection

February 19, 2024

PXS-4728 by Syntara for Sleep Disorders: Likelihood of Approval

PXS-4728 is under clinical development by Syntara and currently in Phase II for Sleep Disorders.

January 25, 2024

Study finds sharp increase in antidepressant dispensing among adolescents and young adults during COVID-19 pandemic

Antidepressant dispensing to adolescents and young adults increased sharply after the COVID-19 pandemic began – particularly among females – a new study finds.

February 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.